RS

Rayavarapu Sai Krishna Revanth

Active Director Director DIN 10833268
DIN 10833268 First appointment Nov 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Rayavarapu Sai Krishna Revanth

Data last updated:

Rayavarapu Sai Krishna Revanth is a Director at Ran Health Pharmaceutical Private Limited (since 2024). The company operates in Pharma.

DIN 10833268
Primary Designation Director
Industry Pharma
First Appointment 11 Nov 2024
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Nov 20242024Active

Board colleagues of Rayavarapu Sai Krishna Revanth

Directorship timeline

Open interactive timeline →
Ran Health Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Rayavarapu Sai Krishna Revanth

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rayavarapu Sai Krishna Revanth

Rayavarapu Sai Krishna Revanth currently holds 1 directorship: Ran Health Pharmaceutical Private Limited (Director, since 11 Nov 2024).

Rayavarapu Sai Krishna Revanth was first appointed on 11 Nov 2024 as Director at Ran Health Pharmaceutical Private Limited.

The current boards of Rayavarapu Sai Krishna Revanth's companies include Gottapu Venkata Murali Krishna Kishore (Ran Health Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available